GlaxoSmithKline Consumer Healthcare Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

GlaxoSmithKline Consumer Healthcare Limited Company Profile :

GlaxoSmithKline Consumer Healthcare Limited is an Indian food processing company. The Company offers malt-based food, protein rich food, cereal-based beverage and nutritional food powder. Its products include nutritional products and over the counter (OTC) products.

The Company’s nutritional products include Horlicks Ninja, Junior Horlicks, Mother’s Horlicks, Horlicks Lite, Horlicks Biscuits, Boost, Maltova and Viva. The Company’s OTC products include Crocin, a household medicine for relieving pain and body ache; Eno, an antacid for instant relief from acidity, gastric discomfort and heart burn, and Iodex, a pain reliever available under various types, including Iodex Double Power, Iodex Headfast and Iodex Ultra Gel.

The Company has manufacturing facilities at Nabha, Punjab; Rajahmundry, Andhra Pradesh, and Sonepat, Haryana. The Company markets its products in India, Sri Lanka, Bangladesh, Nepal, the Middle East, Myanmar, Kenya and Pakistan.


Glaxosmithkline Consumer Healthcare ResultsBSE Code : 500676
NSE Symbol : GSKCONS
ISIN No. : INE264A01014
Industry : Packaged Foods
Face Value : Rs. 10.00


If you are an investor who has shares of Glaxosmithkline Consumer Healthcare or you are an stock market analyst then i am sure you might for Quarterly Results of Glaxosmithkline Consumer Healthcare.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Glaxosmithkline Consumer Healthcare. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Glaxosmithkline Consumer Healthcare.

Glaxosmithkline Consumer Healthcare Q1 Results 2016-17 :

Glaxosmithkline Consumer Healthcare will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit  –
Equity  –
EPS  –

Glaxosmithkline Consumer Healthcare will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit  –
Equity  –
EPS  –

Glaxosmithkline Consumer Healthcare will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit  –
Equity  –
EPS  –

Glaxosmithkline Consumer Healthcare will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit  –
Equity  –
EPS  –

Glaxosmithkline Consumer Healthcare will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit  –
Equity  –
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Glaxosmithkline Consumer Healthcare Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 4308.73
Other Income  278.74
Total Income  4587.47  –
Expenditure  -3473.85  –
Interest  -0.79  –
Depreciation  -57.44  –
PBT  1055.39  –
Tax  -368.48
Net Profit  686.91  –
Equity  42.06  –
EPS  163.34  –

Note : If you like this information about Glaxosmithkline Consumer Healthcare Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.